TAG:
commercial laboratory
Unilab, DIANON Systems, UroCor Report 1998 Financial Results
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
OPTIMISM REIGNS at California-based Unilab Corporation. Revenues are up, operating profits are increasing, and company officials are now talking about growth plans. For 1998, Unilab generated revenues of $217.4 million, compared to $214.0 million in 1997. …
Movers & Shakers For ’99 Demonstrate Leadership
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
EACH YEAR IT BECOMES more difficult to make final selections for our annual Movers & Shakers awards. The reason is simple. Today there are more examples of leadership in the laboratory than when we first started these selections three years ago. This is a good omen. It means that the crucible of…
Sales & Marketing Is Critical To Success Of Labs & Pathologists
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
CEO SUMMARY: Careful study of the most successful lab oratories operating today reveals a common characteristic: the effective use of sale s and marketing methods to boost specimen volume, revenue, and operating profits. This is true whether it’s a hospital lab outreach program, a comme…
Three Blood Brothers Release Year-End Financial Performance
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
FINANCIAL REPORTS RELEASED by the three national laboratories for the fiscal year 1998 reveal a definite improvement in their financial performance and cash flow. One sign of this improvement is the fact that none of the three blood brothers disclosed any huge write-downs similar to those experience…
DARK REPORT Picks 1998’s Ten Biggest Lab Stories
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY: Our story picks for 1998 demonstrate a broad range of subjects. Each affects laboratories and pathology practices in significant ways and should be used to trigger appropriate management strategies. Two essential themes among this year’s ten biggest lab stories: continued d…
Total Laboratory Automation: It’s “ DOA” In Today’s Market
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY: Since 1994, thoughtful lab executives have wrestled with the concept of total automation for their laboratory. Despite concerted marketing efforts by some of the world’s most successful diagnostics manufacturers, only a handful of total laboratory automation (TLA) sites are…
What’s Next For Regional Laboratory Networks?
By R. Lewis Dark | From the Volume V No. 16 – November 30, 1998 Issue
SINCE THE CONCEPT OF REGIONAL LABORATORY NETWORKS burst on the scene in 1995, I have ardently believed in their potential to help hospital laboratories remain relevant in the world of managed healthcare. The early victories of Pittsburgh’s Regional Laboratory Alliance and San Franc…
Medicare Refund Request Issued To AmeriPath, Inc
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
CEO SUMMARY: Regulators believe AmeriPath’s Ft. Lauderdale laboratory submitted claims during 1996 which were based upon improper procedure codes or lacked adequate documentation. AmeriPath “vigorously” disputes the situation. It is still uncertain as to whether this action represen…
Washington’s PacLab Network Succeeds With Standardization
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
PART TWO OF TWO PARTS CEO SUMMARY: In part one of this two-part series, we looked at how changes to healthcare in the state of Washington brought about the creation of PacLab Network Laboratories. In this concluding installment, we explore how PacLab is standardizing lab…
Kaiser, SBCL To Automate Pap Smear Screening
By Robert Michel | From the Volume V No. 15 – November 9, 1998 Issue
CEO SUMMARY: Two of the country’s largest Pap screen testing organizations are preparing to introduce automated primary screening into their laboratories. NeoPath’s con- tracts with SmithKline Beecham Clinical Laboratories and Kaiser Permanente mark the beginning of a new market cycle…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized